Anandamide is also a lipid mediator that functions as an endogenous ligand (a protein that binds to a recptor) by attaching itself to the body’s CB1 receptors, the primary molecular target that’s responsible for the pharmacological effects of THC. Anandamide was discovered in the early ‘90s by Dr. Raphael Mechoulam, who was known for his groundbreaking research and discovery of delta-9-THC while trying to figure out why our bodies contained cannabinoid receptors that are capable of binding with external cannabinoids such as CBD and THC.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…